SA22 Tepotinib Versus Chemotherapy in Met Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Real-World Evidence (RWE) and Matching-Adjusted Indirect Comparison (MAIC) to Explore the Impact of Subsequent Therapy
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2931
https://www.valueinhealthjournal.com/article/S1098-3015(23)06062-X/fulltext
Section Title :
Section Order :
12260
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)06062-X&doi=10.1016/j.jval.2023.09.2931